Ignite Creation Date:
2024-05-06 @ 4:17 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04933227
Status:
TERMINATED
Last Update Posted:
2024-03-12
First Post:
2021-06-17
Brief Title:
A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction GEJ
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stomach Neoplasms |
| Gastric Cancer |
| Gastroesophageal Junction Adenocarcinoma |
Keywords: